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Abstract 
 
Background:  MRI is a medical imaging method that does not use harmful or ionizing 
radiation so it is safe and can be used to measure the proportions of iron that accumulate 
in the organs of the human body, especially the heart and liver. 
Methods and sample:  The study was conducted on 50 patients suffering from major 
thalassemia and treated through chronic blood transfusion, as well as 20 other patients 
who do not suffer from Thalassemia or any diseases in the heart or liver through the use 
of their medical files and their medical history  in Alia Governmental Hospital . Magnetic 
Resonance 1.5 Tesla-type Philips Ingenia . 
Retrospective case control  study was carried out in the period between December 2018 to 
March 2019 at the Hebron Governmental Hospital. The Results were compared between 
liver and heart T2* with SF levels, On one hand and on the other hand results compared 
between LIC  and MIC with T2*, and LIC with MIC. 
Results: The average of SF in patients with thalassemia major was 2150 ng/ml (SD 
179ng/ml).  positive correlation was found between LIC and MIC with SF, also positive 
correlation was found between SF and T2* of liver and heart .and significant relation 
between LIC and MIC.  
 Conclusions: Although the serum ferritin levels normal and abnormal were found among 
major thalassemia patients, there were results showing elevated iron concentrations in the 
liver and heart of major thalassemia. There is an urgent need for new and accurate studies 
to prove the importance of MRI for Determine the location and quantity of iron 
accumulated in the muscle of the liver ,Heart and other organs especially that this 
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procedure  safe and harmful, In order to give the correct and accurate chelating treatment 
and follow up and control the improvement in the reduction of iron ratios accumulated. 
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Chapter  One: 
 
___________________________________________________________ 
Introduction 
 
Thalassemia patients who are treated with blood transfusion to raise the level of 
red blood cells and raise their hemoglobin levels. Continuous blood transfusion causes 
iron to be elevated in the body. Each blood unit contains 250 mg of iron[1]. 
Ferritin  serum, which acts as a blood test, does not give full or correct accuracy to 
the high concentration of iron in the tissues of the body, since the blood test gives the 
rates  of Ferritin and trans ferritin  that pass through the blood and may be high because of 
inflammation in the patient or cancer so this is not accurate reading, They are 
comprehensive[2].   
Scientific studies on the accumulation of iron in the heart and liver proved a direct 
relationship between high serum ferritin ratios and excess iron in the organs of the human 
body, but it was difficult to determine the amount of iron in the heart compared to the 
liver because of the nature of absorption of iron at the heart of the complex [3-6].  
Previous studies have shown a weak relationship between high ferritin and excess 
iron ratios in the heart muscle[7,8]. This study was therefore important in showing the 
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depth of the relationship between the upper ferritin ratios and the iron accumulated in the 
liver and heart muscle, using the MRI for thalassemia patients. 
1.1 Statement of the problem: 
Since the blood serology test through which the serum Ferritin levels  indicate the 
iron levels the body, the fact that the serum Ferritin gives in general and does not 
determine the organ who had high iron stores in the body, on other hand the Serum 
Ferritin levels in blood raised when the patient have diseases like infections or cancerous 
diseases, the urgent need for a safe method is invasive cheap and not painful, such as 
Magnetic Resonance Imaging for a careful study to determine the amount of iron in the 
Heart muscle and Liver and modify chelation therapy. 
1.2 Study objectives : 
The objectives of the present study are : 
1-How MRI application improve and determine the concentration of iron in the    
cardiac and liver. 
2- To develop appropriate adjustments  daily clinical practice and  explore 
possible complications related to iron.  
The specific aims for our study distributed into:  
1-Validation of MRI based method (T2*) in determining the amount of iron 
concentrated in both liver and myocardium  detection and quantifications.  
2-Imphasize the dual echo of in-phase and out-phase of MRI imaging for Heart 
and  liver iron overload in the body.  
3-To produce high image quality for heart and liver  using T2* analysis with 
accurate labeling on the region of interest. 
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1.3 Research significance: 
The main goal of the project is to provide accurate image quality and efficient 
imaging directed at T2* analysis.  And to prove that MRI is a safe, harmless and accurate 
method to determine the site and amount of iron accumulated in the Myocardium and the 
liver muscle liver and the correlation of both with each other’s and with the serum 
Ferritin levels. 
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Chapter  Two 
_____________________________________________________________ 
Literature Review: 
2.1 Definitions 
Ferritin: Is an excess iron stores  in the human body, which is found in liver cells(hepatic 
cells) and in the immune system (reticuloendothylial ) in the body as the human body 
does not make iron, but it is acquired from the food we eat[11]  . 
Iron: One of the most available elements in the human body, which is estimated 3-4 gm, 
which is necessary in the process of metabolic rate in the body and needed by the cells of 
the body where the red blood cells[12]. 
MRI:  One of the methods of the medical imaging technology which is  non-harmful, 
which does not contain harmful or ionizing radiation ,and depends on the property of 
relaxations in the protons after exposed to pulses of radio frequency waves, and is the 
most accurate medical medical imaging technology,  used three-dimensional imaging, it 
became the useful way which has been used in the detection and quantification of iron 
overload in different body organs [13]. 
Thalassemia: Is one of the most common blood diseases in the Mediterranean, which is 
caused by a decrease in the number of red blood cells and a decrease in the level of 
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hemoglobin, which is treated through the transfer of blood to the patient in order to 
maintain a high quality life. [15] 
T2*relaxation: It is a method of magnetic resonance imaging that used the gradients 
echo pulses in order to make rephrasing of protons in fasten way using small Flip Angles 
(less than 45°) and short TR ,TE,…..with special analysis program, the T2* hav 
transverse decaying process. [16]  
2.2 Pathophysiology of Iron Overload 
The disease of accumulation or increase of iron in the organs of the human body is 
a very serious disease on the organ that has high rates of the Iron overload disease and 
may lead to failure of that organ like Heart failure ,Hepatic failure ,Cardiomegaly 
,hepatomegaly, and destruction of cells, Iron oxidation lead to produce free radicals 
which show cancer in the body [18]. 
The majority of these diseases caused by the increase of iron caused by the 
process of chronic blood transfusion, which in turn causes the accumulation of the Iron 
and therefore called the silent disease  [19]. 
Since Magnetic Resonance Imaging is a safe and harmless method, the need to 
limit the iron that concentrated in organs in very important using the relaxation speed of 
the cells that contain excess iron and therefore we can determine if the member has the 
disease or not [20,21]. 
There is a clinical need to use quantitative and vastly method  to avoid excess 
accumulation of toxic iron in those tissues and monitoring the treatment process [22]. 
So that the MRI is the accurate and invasive process ,and can be used frequently 
to monitor the Iron levels  in organ during the treatment plane[15]. MRI based on 
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determining the iron overload in the both liver and heart muscle the process of Transverse 
Relaxation time of proton (T2*) and Through the formulas of calculating the amounts of 
IRON [16]. The  sensitivity of IRON in liver is highly marked[17]. T2* provide vastly 
relaxation while SIR provide  the amount of signal  produced from the tissues 
.quantitative information on the concentration of iron in the heart muscle and liver have 
correlation coefficient highly marked also  [18]. On other hand Iron concentration is 
inversely proportional to T2*relaxation, while SIR directly proportional to IRON 
overload   [19]. 
2.2.1 MRI in Palestine  
In Palestine There are many magnetic resonance imaging (MRI) machines in 
Palestine. There are a large number of tests that done monthly , which are estimated to be 
more than 5,000 tests . However ,the iron detection and quantification test does not 
applied in Palestine, we urgently need to apply this method of imaging in order to be 
routine test daily done . And publicize them in the private and public sectors in order to 
serve the patients of the major thalassemia and follow up their treatment. 
 . 
The imaging of the liver muscle and the myocardium using the technique of 
Transverse  Relaxation Time which called T2* is an easy way have a special program that 
analyzes the values of the labeled region of interest and then the results through special 
equations applied and a special computer program had processed . and there are special 
parameters shown in tables 2.1 and 2.2. 
7 
 
2.2.2 T2* protocols  for MRI imaging of Heart and liver . 
 
Table 2.1: T2* heart Parameters. 
 
Pulse sequence Multi echo GRE 
Coil Phased array 
Slice Thickness 10mm 
Matrix 96-128 x 64-96 
FOV 40 x 25-40 (can increase to reduce initial 
TE) 
Bandwidth Maximum 
Flip Angle 20 
TR 100ms 
TE Minimum possible (ideal ≤1.0ms) 
TE intervals 0.75 to 1.0ms 
Number of TEs 10 
Fat saturation On 
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Table 2.2: T2* liver Parameters 
 
Pulse sequence Multi echo GRE 
Coil Phased array 
Slice Thickness 10mm 
Matrix 192 – 256 x 108 – 128 
FOV 40 x 25-40 (can increase to reduce initial 
TE) 
Bandwidth Maximum 
Flip Angle 20 
TR Minimum – fixed 
TE Minimum possible (ideal 2.0 to 3.0ms) 
TE intervals 1.0 to 2.0ms 
Number of TEs 10 
ECG triggering On 
Sequence type Black blood or bright blood 
Trigger delay Bright blood: minimum; black blood. 
Flow compensation On for bright blood / off for black blood 
Fat saturation Off 
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2.2.3 Prognosis of thalassemia   
Iron Overload in the liver and heart, resulting from genetic defect  in blood 
disorder , which is treated through the blood transfusion , which caused in the 
accumulation of iron in the body organs ,which  are diagnosed previously through the 
blood test, looking fore  the amount of Ferritin levels in the body and there are other 
methods such as biopsy which is painful and sometimes the patient is subjected to 
complications and enter to the hospital, so we need Magnetic Resonance to evaluate the 
Iron ,which involves the use of T2* relaxation time in determining the ratio of iron 
through signal intensity ratio (SNR).  
 
2.2.4 Thalassemia Treatment 
 Patients suffered from  Iron overload are treated with special drugs that emulsify heavy 
metals in the body, which called the chelating drugs, like deferoxemen the doses depend 
on the amount of Iron concentrated in the organ needed for treatment [19].   
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Chapter  Three: 
_______________________________________________________________________________ 
Methodology 
 
3.1 Introduction: 
In this chapter, the researcher will explain the place of study and the study 
community, determine the description of the study, the sample used, the method of 
imaging, the materials and the equipment used in this work, in order to work a precise 
scientific method. 
 Using fast MRI T2* analysis program, as protocol focusing on assessment of 
heart and liver iron overload using Relaxation in the transvers plan, with  short study time 
less than 8 minutes[20].  any exam may be done in a any day.   the responsible for 
selecting the patients is hematologist, according to the clinical need for the MRI exam, 
and provide basic background clinical data (hematocrit ,age, sex, serum ferritin levels,  
chelation drugs, HB.).  The scheduling are arranged with the MRI department in Hebron 
Governmental Hospital . 
The results are analyzed by the radiologist and the Hematologist and stored in the 
patient files in order to follow the cases. In a following step regulation, images will be 
uploaded to a hospital server..  
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3.2 Pilot study: 
Radiology Department at Hebron Governmental Hospital by 1.5 Tesla MRI 
machine Type Philips Ingenia. The Radiology Department. That contain one 16 slice CT 
machine , tow X-ray machines one Computed Radiography CR. And one full DR.  Alia 
hospital contains 400 bed, hematology , blood bank, surgery, neonate, gynecology, 
medical departments. 
3.3 Research setting: 
Hebron Government Hospital south of Palestine. where the study was conducted 
in the West bank in on patients with major-thalassemia ages  between 11-31 years old. 
Patients sampled with all there complete blood counts tests their ferritin serum. At the 
same time, a measurement of iron levels in liver and the Heart was done by MRI T2 
*protocols  and then, the results were compared and stored in medical files in the 
radiology dept. 
3.4 Study population: 
The study population consisted 70 cases, 50 patients suffering from thalassemia 
major and taking blood many ,in Hebron Government Hospitals in West Bank of 
Palestine. 20 patients as control cases with no Heart or Liver disease ,and never had blood 
transfusion treatment, from different regions in Hebron. The patient scanned by the T2* 
protocol, without any fasting or  contrast ingestion or  injections. 
 A printed report of the scan patients including both heart and liver iron 
concentrated assessment is provided to hematologist within one day of the scan.   For all 
patients, a clinical data and testes  including age, sex, any diseases, transfusion history, 
chelation drugs  and doses, HB level, ferritin level and of splenectomy is collected from 
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medical records in Hebron Hospital by the hospital information system after the ethical 
confederations . 
3.5 Sample size: 
50 patients suffering from thalassemia major and taken blood transfusion  (old, 
range: 11-31years old; 76% males) were chosen for the study, and 20 controls patients, 
coming to MRI examinations from December 2018 to March 2019. this research was 
approved in hospital by the administration, in addition consent form done by the patients 
themselves and patients privacy .  
3.6 Inclusion criteria: 
a. Patients with chronic regular blood transfusions or with high serum ferritin level, 
who can enter the MRI without any problems.  
b. Patients ≥ 11years old. 
3.7 Exclusion criteria: 
Patients have defibrillators, cerebral aneurysm or clips contra-indications to MRI 
exams, permanent pacemakers,…. etc. 
3.8 Research design: 
Retrospective cross sectional  case control study design. Which is a design that is 
best choose when comparing between patients complaining from a certain disease with 
others that has not been diagnosed with that disease of interest, the prevalence of risk 
factors or phenomena in one of the major benefits that may be the easy, short time 
consuming, costless,  and the best design to investigates risk factors or comparing results 
in between positive and negative cases of interest disease . 
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Also the researcher used this study design after  the existing medical files and 
hospital information system of the Alia (Hebron Governmental) Hospital comparing 
patients suffering  from thalassemia major  with other control cases without blood 
transfusion history , that coming to routine MRI exams Governmental Hospitals. 
3.9 Data collection methods: 
Researcher used different Data in his research including  
 Data files, that included  
o Personal data 
o Medical files and history 
o Demographics 
 HIS of Hebron Governmental  Hospital that included 
o MRI images 
o Medical file  
o Lab tests 
Medical files at Hebron  Hospital are gathered and collected to get information 
about iron concentration in liver and cardiac muscle, using  Magnetic Resonance Imaging 
in the Hebron Governmental Hospital. The study included 50 patients with thalassemia 
major who receive chronic treatment through regular blood transfusions and chelation 
therapy. Iron concentrations in both the heart and liver were detected  through MRI. All 
participating patients were referred from the Hematology Department in hospital. 
The information about the patients was recorded, to information related to 
laboratory tests such as hemoglobin in the blood and the proportion of ferritin serum.  
14 
 
such as the age of diagnosis, the medication received by the patient for treatment, and In 
addition to the number of blood transfusions.  
A group of 20 case who had never received blood transfusions were taken as 
control group. This group was of patients arriving to MRI exams other than the liver and 
heart. This group was selected studying  their medical records and previous history, 
making sure that they are not suffering from previous liver and heart diseases. Also, 
group of this patients were aged 11-31 years. 
Regard to pediatric patients, consent form of their parents taken for the 
examination of this study. In addition, patients older than 11 years old, have been 
approved for MRI that can enter MRI without problems . The exam done using the body 
coil (Torso coil) on a 1.5-T (PHILIPS-INGENIA). Multiple Echo Gradients, T2* slices 
images were taken on the localizer image as shown in (Fig 3.1). 
Several images during the single breath-hold with 8-10 echoes, first echo time 
(TE) of 0.9 ms, and ΔTE = 1.1 ms, and (TR) of 180 ms. Each sequence of protocol take 
about  eight to ten  minutes of time.  
TE signal intensity measured by,  drawing a region of interest (ROI) , area of 1–
1.4 cm
2
 was taken on the accurate region . ROI in liver muscle was identified by drawing 
it in the right lobe, that don’t contain any blood vessels or bile ducts as shown in (Fig 
3.1). The Hankins [20] equation used to emphasize  the signal intensity of the different 
TE values which obtained in the imaging slices  using the Excel sheet. 
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Fig 3. 1 Pilot and axial slices for Liver and heart . 
 
(a)                                                                         (b) 
 
Fig 3. 2 ROI. For liver (a) and heart (b). 
 
The T2* values or the reciprocal R2* (=1/T2*) is calculated by using a gradient 
echo protocol, which used to measure the concentration of iron accurate than the T2. 
However, the loss of the signal in cases of high iron  is very fast due to the strong local 
variations in magnetic field and inhomogeneity , this is known as susceptibility effects. 
For example, the iron molecule contains a high sensitivity to the magnet, which had long 
magnetization victor in the transverse plan , and this high magnetization detected by  
T2*gradients echoes sequence [21]. 
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There is a linear relationship between liver T2* with iron cincentration/ and R2* 
that verify the iron over load in liver,  Fig (3.3) shows MR images show the degree  of 
liver IO in the four grades levels of iron, and ROIs of the liver SIR measurements. The 
amount of iron concentrations in the liver (LIC) was calculated by using the following 
equation[22] : 
[  ]                               ⁄   where R2* is 1/T2* (Transverse 
relaxation rate by gradient echo). 
HeartT2* we used the basic method in determining  the amount of iron 
concentrations. T2*  is accurate than T2 imaging in the calculation of the iron 
concentration of myocardium because it depends on gradient echo sequences  instead of 
spin-echoes which is faster in slicing images  [23]. In tissues having a few iron 
concentrations both of  R2* and T2* used as in the Heart muscle. The different TEs  
echoes value were used to determine the signal intensity,  was done using the formula: SI 
= e–TE/T2*[17]. 
For myocardial iron concentration (MIC), the gradient echoes was taken in single 
breath hold  using the  vital gated like the ECG. The triggering heart rate  was used in 
conjunction with the heart cycle. 
Images were  taken during the ventricles contraction ,using the same parameter for 
every echoe . The protocol parameters  taken with  single breath hold were as follows: TR 
= 180 ms, 8-10 echoes, TE1 = 1.2 ms, and longest TE2 of 21 ms. To measure the signal 
intensity from heart muscle  in the period of ventricles contractions , the ROI was drawn 
with a 1.0–1.2cm2 as shown in (Fig 3.4). The MIC was determined using this equation: 
[  ]                  where T2* (Transverse relaxation rate by gradient echo) 
[24]. 
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While the excel sheet for  MIC value was calculated using the following equation 
[25]: 
           
   
   ⁄  
Where SI (TE) is the signal intensity at particular TE and A is the computational 
SI at TE=0[12]. Values of cardiac T2* (CT2*) <20 ms were considered to indicate 
cardiac diseases  which was classified as milled to  moderate (10 ms< CT2* <20 ms) and 
severe when (CT2* <10 ms)[22]. LIC >3 mg/g dry weight (dw) was considered to be 
liver disease  which was classified on severe (LIC >15 mg/g dw) , moderate (7< LIC <15 
mg/g dw),   mild (3< LIC <7 mg/g dw) [12].  
According to the statistical analysis in this study which  based on SPSS software 
version 18. The Average values of LIC, MIC, and SF were calculated. In addition, the 
correlation  coefficient was calculated for MIC, LIC, T2*, and SF levels. for comparison 
of mean values T-test was used.  p< 0.05 was considered to be a significant change. The 
other different values  were analyzed by the correlation coefficient.  
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Fig 3. 3 MR axial  images of the four  grading of liver IO, and ROIs of the liver 
demonstrating  SI  measurements.   
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Fig 3. 4 severe heart iron concentration  evaluated with ROI (rejion of interest) in 
the  ventricular septum. 
 
3.10 Signal Intensity Ratio (SIR): 
Signal Intensity Ratio depends on the signals that collected from the tissue and 
noise. The signal intensity of the tissues that do not contain iron like musculoskeletal 
muscles  and fat, is accurate method to compare the  tissues  that containing high  iron 
where the signal drops off. The torso  body coil used to acquire the liver slicing  images 
[27]. The liver  ROI is placed in a non-blood vessel or biliary ducts to avoid any possible 
of  artifact. When we want to  make a comparison, fat and  skeletal muscles are the best 
reference to MRIT2* analysis. Comparing to skeletal muscle, the high iron overload liver 
has higher signal intensity. Therefore, the signal intensity from liver containing iron 
overload can be easily  distinguished. The sequences  parameters of the T2* protocol  
including the Bandwidth and voxel size which should be accurate because  it affected the 
liver to muscle signal intensity ratio. other tissue can be used as reference for signal, but 
the fatty  signal intensity really  is significant compared with  the tissue of the liver , also 
it has significantly different  between children and adults[20] . 
Myocardium measured in two ROI one in the right and the second in the left 
paraspinous muscles, while the liver signal  intensity measured at region of interest 
located  in the right lobe avoiding vessels. Therefore, mean signal intensity of the liver 
that calculated by taking ratio between liver and muscle or fat with same size of ROI. 
And band width. Increasing LIC will decrease the intensity of liver/muscle ratio [21]. 
Thus, the LIC values greater than 400 μmol/kg (22.5 mg/kg) cannot be accurate  
quantified [12]. Proton density or the exponential ratio may cause SI alternative so that 
TE/T2 to the following equation may be used as a solution of this alternating  [25]. 
20 
 
       (    
  
  )            
Si: signal intensity ,NH: intensity at 0 time ,e :exponential rate, TR :repetition 
time , T1:longitudinal recovery time ,TE: echo time ,T2* decaying in transverse plane. 
3.11 Statistical analysis: 
(SPSS) version 18 ,used for the collected and analyzed data.  T test and P value, 
was used to analyze the variances  in concentration of iron in both liver and heart muscles 
between thalassemia major patients and normal participants  using a two-tailed student’s 
T test as appropriate statistical way . Results are expressed in both mean and  ±SD.   
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Chapter  Four: 
_____________________________________________________________ 
 
Results and Discussion: 
4.1 Results: 
 Liver and Cardiac iron detection   was done for 50 patients  with thalassemia 
major, were enrolled in this  study.  With  age between  11–31 y (mean 20.6 ± 6.18 SD, 
median of 21), of which 38 (76%) were males and 12 (24%) were females.  20 patient  as 
controls  with age range was 11- 31 y (mean 21.6± 5.64 SD, median of 21Y), of which 12 
males were (60%) and 8 females were(40%). 
The distribution of the six  in the controls and cases was not statistically 
significant (p<0.15). The height range of the controls  was 123–166 cm ( mean 158.5 ± 
10.2 SD) and of cases was 136–165 cm (mean 161.7 ± 11.45 SD), there are  not 
statistically significant difference found  (p <0.51). The weight range of the controls  was 
53–85 kg (mean 67 ± 13.4 SD) and of cases was 52–85 kg (mean 67 ± 12.1 SD), we don’t  
found  difference  statistically significant (p>0.422).  
ALT range values  of the controls  was 14–148 U/L (mean 48.3 ± 25.4 SD) and of 
controls was 17-29 U/L (mean 17.50 ± 4.7 SD), there is statistically significant difference  
(p < 0.001). AST range among  the cases was 13–123 U/L (mean 13.4 ± 17.6 SD) and 
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among the of controls was 12–26 U/L (mean 17.50 ± 2.7 SD), there is statistically 
significant found  (p < 0.001).    Hemoglobin levels of the controls was 11.4–14.8g% 
(mean 12.8.4 ± 1.12 SD) and of cases was 6.7.2–10.1 g% (mean 7.49 ± 0.741 SD), there 
is statistically significant difference  (p < 0.001).   
 
SF of the patients with thalassemia major  was averaged  2150 ng/ml (SD 
179 range: 96–12,8 median: 1621.5). While the mean SF among the controls was 
88.7 ng/ml (SD 15.03, range: 42–121, median: 74.5). 
There is 8 previous splenectomy between the cases. But don’t  show any   
statistically significant differences in patients with and without splenectomy in the 
values of  , heart T2* and MIC, liver T2*, LIC and SF levels values. 
Among the 50 case, mean LIC was 5.696 mg/g (SD 8.879, range: 0.43– 31.6, 
median: 2.29) and mean LIC in controls was 0.65 mg/g (SD 0.34, range: 0.1–1.1, median: 
0.82).  
41 patient with abnormal LIC and 9 patient with normal LIC values among the patients 
with thalassemia major and taking blood transfusion regularly . 
  Among the 50 patients with thalassemia major, 9 (18%) patients were having 
normal liver   T2*>6.2ms., while 14(28%) patients were mild T2* 2.2-6.1 ms. 15 (30%) 
patients having moderate T2* 1.4-2.1ms, 12(24%) patients having sever T2* < 1.4ms . 
liver T2*, R2*, LIC ,Heart T2*,R2*for heart and MIC in the 50 patients with 
thalassemia major,  and  SF levels that have abnormal and normal values  are shown  in 
Table 4.1 . there is significant variation  (p < 0.001) was seen in mean LIC between group 
of cases having normal and abnormal SF levels  . on other hand There was a significant 
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difference found in MIC (p < 0.001) between the  cases with normal and abnormal SF 
levels. 
Table.4.1: Mean Liver T2*, R2*, LIC and Heart T2*, R2* MIC among cases with normal 
and abnormal SF 
Parameters Liver T2* 
Mean (SD) 
Liver R2* 
Mean (SD) 
LIC 
 Mean (SD) 
 Heart T2* 
Mean (SD) 
Heart R2* 
Mean (SD) 
MIC 
Mean 
(SD) 
Normal SF 19.14 (13) 93.4 (76.7) 1.6 (2.3) 46.19(7.17) 19 (6.6) 0.61 
(0.19) 
Abnormal SF 3.2 (3.2) 562.4 (121) 5.696 (8.69) 22.7 (10.1) 53.4 (34.2) 1.5 (1.3) 
LIC Liver iron concentration; MIC Myocardial iron concentration; SF serum ferritin 
 
        Regarding to the 50 patients with the thalassemia major , 9 (18%) patients had 
normal (degree one) LIC, 10 (20%) patients had degree 2 (light) LIC, 13 (26%) patients 
had degree 3 (moderate) LIC, and 18 (36%) patients had degree four (severe) LIC.  The 9 
patients with  normal LIC  in the cases also had normal MIC, while  27 patients had 
normal MIC and 23 had abnormal MIC among the 41patient  with abnormal LIC.  
    Table 4.2.demonstrate the distribution  of the normal and abnormal MIC and LIC of the 
50 patients having thalassemia major and taking blood transfusion regularly , 9 patients  
normal LIC , 41 patients with abnormal LIC, 27 patients with  normal  MIC , 23 patients 
abnormal MIC , 23 patients with abnormal LIC  and MIC . 
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Table .4.2: Distribution of cases with normal and abnormal LIC and MIC 
LIC liver iron concentration; MIC Myocardial iron concentration  
In the 50 patients with the thalassemia major , 5 (10%) patients had grade 4 
(severe) MIC, 4 (8%) patients had grade 3 (moderate) MIC, 14 (28%) patients had grade 
2 (light ) MIC, and 27(54%) patients had normal (grade 1) MIC.  
The 27 cases with normal MIC, 9 had normal LIC and 18 had abnormal LIC.  
Cases with normal MIC the average SF  levels was 543.5 mg/g, and in cases with 
abnormal MIC SF levels was 5378.8 mg/g.  
There was a significant differences was seen between the mean SF levels in the 
cases with normal and  abnormal MIC (p < 0.01).  
 In the figure 4.1 there is positive correlation between Liver and heart  T2* with 
SF levels (r = 0.314, p< 0.013) .  
 
 Normal MIC (%) Abnormal MIC (%) Total (%) 
Normal LIC 9  (18%) 27 (54%)  9 (18%) 
Abnormal LIC  41 (82%) 23 (46%) 41 (82%) 
Total  50 (100%) 50 (100%) 50 (100) 
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Figure 4.1. correlation between heart and liver T2* with Serum Ferritin. 
LIC had positive correlation with SF (r = 0.531, p < 0.001). MIC had positive 
correlation with SF (r = 0.427, p < 0.001). 
          Also there is positive correlation coefficient between  Liver and heart T2* (r = 
0.344, ). 
(p<0.01). 
         There was also positive correlation found between LIC and MIC (r = 0.437, p< 
0.001) as shown in figure 4.2 . 
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Figure 4.2. Correlation between MIC and LIC. 
4.2 DISCUSSION: 
The results of this study  show that MRI T2* imaging and analysis can be used as 
invasive tool for detection and quantification  of iron  overload in both liver an heart. 
Biopsy of these at thalassemia major patients who receive blood transfusion  as chronic 
that used  to detect and quantify  the iron concentrations is invasive and inaccurate. In 
addition, sometimes requires patients to enter the hospital due to the complications in 
about 0.5% of cases with thalassemia major [28]. 
. Also this study showed that a high MIC and LIC, in spite of the rate levels, of SF 
is low in these patients. This gives  impression that the chelation therapy should be 
increased.  
T2* MRI is non-invasive (not needing hospitalization) . This technique showed 
that , the ability to determined  iron concentrations in the liver muscle  and myocardium  
has become measurable. The basis of this technique is to accelerate relaxation T2*  signal 
decay, this  because T2*W gradient echo (GRE) images with iron overload  is vastly 
decaying and  better than the signal in T2W spin-echo [19]. When iron  is overloaded in 
y = 0.0858x + 1.1469 
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tissues the SIR is high and  higher the darkening images . The darker areas mean that high 
iron concentrated and this leads to shortening relaxation time and vastly drop in signals  
[29]. 
The variances  in the inhomogeneity  of the magnetic field, results from increased 
the degree of iron overload  allow GRE sequences to be the  better sensitivity  than spin 
echo sequences. This is due to inhomogeneity and spin spin relaxation process [23]. Also  
MRI considered to be  safe technique that  it does not produce ionizing radiation, it is 
very safety  in children medical  imaging especially  when need for follow-up treatment 
and monitoring  [22]. 
The result showed positive correlation between SF and LIC and between SF and 
MIC. However, the correlation of SF level with LIC was positively more than MIC. with 
increase SF level, the iron burden would increase [27]. 
In patients with thalassemia major , the relation  between heart T2* and SF values 
was positive correlation  (r = 0.40, p< 0.0004). but it was seen  negative correlation by  
Voskaridou et al[4]. 
In this  study the correlation between liver and heart T2* with SF (r = 0.314, p< 
0.01) is positive. Also The relationship between SF and LIC (r = 0.531, p < 0.001) is 
positive correlation , correspond to the previous article [21]. On other hand  there is 
relationship between liver and heart T2* (r = 0.344, p< 0.011)which is also positive . At 
the same time, the relationship between LIC and MIC was positive (r = 0.437, p 0.002). 
While Christoforidis et al[8] found that  there is better relationship between Liver 
T2* and SF levels, identical to the results of this study,   (r = 0.342, p < 0.001). But  Heart 
T2* MRI (r = -0.186, p <0.011) [30] opposite this study . Also he founds a moderate 
relationship . 
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This study proved positive relationship between the amount of iron in Heart and 
liver, this relationship  with positive correlation , also the relationship between the 
relaxation of the liver and heart with iron overload  is positive and significant relationship 
in spite of low levels of SF. with SF levels.  
29 
 
 
 
 
 
 
 
 
Chapter  Five: 
_____________________________________________________________ 
 
Conclusion, summary , recommendation: 
5.1 Conclusion: 
MRI considered to be the safe and accurate way to determine, and measure the 
amount of iron that deposit and  accumulated in the muscle of the liver and heart, through 
the use of the property of relaxation techniques, that decaying in the transverse plan ,  the 
rat of the  speed of the  relaxation increases with the increase in the amount of iron stored 
in the tissue of the organ that  need to be examined, and can calculate the amount of iron 
accurately through the use of special equations, The liver and the heart depend on the 
percentages of arising  signals from the tissue of the cell, which increases with increasing 
the proportion of iron, which makes it accelerate in decreasing,  MRI is a  non-invasive 
and non-painful  technique used for assessing the amount of iron in the liver and the heart 
muscles, and in the near future it is expected to be used frequently for this purpose to  
make monitoring treatment and chelating drugs  plane and doses. 
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5.2  Summary : 
1. Iron overload lead to liver cirrhosis, congestive heart failure, hepatocellular 
carcinomas and endocrine damage . 
2. Iron  can be calculated and measured by using T2* method in any organ of the 
human body . 
3.  Iron concentrated in liver or heart  treated by chelating drugs so it is necessary to 
monitoring an follow up patient treated by using MRI  T2* analysis. 
4. The percentage of IRON deposit  in organ leads to increase the signal intensity an 
vastly decaying  . 
5. Accurate  chelating dose can be determined by the amount of Iron concentrated in 
liver and heart which is determined by T2* analysis . 
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 المغىاطيسي تالرويه التصوير تاستخذام القلة وعضلح الكثذ في الحذيذ وقياس كشف
 إعذاد: تسام عثذ العزيز موسى أتو عرقوب
 المشرف: د. محمذ حجوج
 
                                                                                                 :الملخص تالعرتيح 
وّ١خ اٌحذ٠ذ  ٌٍىشف ػٓ  ٘ٛ ٚع١ٍخ إِخ ٚغ١ش ِؤر٠خ  رغزخذَ اٌزصٛ٠ش ثبٌشٔ١ٓ اٌّغٕبؼ١غٟ  ثحث:خلفيح ال
اٌٝ رم١١ُ وً ِٓ رشو١ض اٌحذ٠ذ فٟ رٙذف ٘زٖ اٌذساعخ  .ٚاٌىجذ ٌّشظٝ اٌزلاع١ّ١ب اٌىجشٜ  ,اٌّزشاوّخ فٟ ػعٍخ اٌمٍت
 ثبٌشٔ١ٓ اٌّغٕبؼ١غٟ . اٌىجذ ٚفٟ ػعٍخ اٌمٍت ٌّشظٝ اٌزلاع١ّ١ب اٌىجشٜ ثبعزخذاَ اٌزصٛ٠ش
ِش٠ط 70ُِٕٙ  ,عٕخ13 -11حبٌخ رزشاٚذ اػّبسُ٘ ث١ٓ  70رٕبٌٚذ اٌذساعخ اٌحبٌ١خ ػ١ٕٗ ِٓ   :الطرق والعيىح  
ٚاٌىجذ ٌٚ١ظ آِ اِشاض فٟ اٌمٍت  ْٚلا ٠ؼبٔٛ ,ِش٠ط  ٠ؼبْٔٛ ِٓ اِشاض اخشٜ70ٚ ,اٌزلاع١ّ١ب٠ؼبْٔٛ ِٓ ِشض 
ص١خ ح١ث رُ اخشاء اٌزصٛ٠ش ثبٌشٔ١ٓ اٌّغٕبؼ١غٟ ثبعزخذاَ خب اٌ١ُٙ ,ٌذ٠ُٙ اٞ ربس٠خ ِشظٟ ٠زؼٍك ثٕمً اٌذَ 
ح١ث رُ اٌحصٛي ػٍٝ ل١بعبد ثٛاعؽخ ٔفظ خٙبص : ٌدّ١غ اٌحبلاد *2T ( (الاعزشخبء اٌؼشظٟ ٚاٌزٟ رذػٝ 
ٚرٌه فٟ لغُ الاشؼخ فٟ ِغزشفٝ اٌخٍ١ً   ,رغلا 0.1اٌزصٛ٠ش ثبٌشٔ١ٓ اٌّغٕبؼ١غٟ ٚ٘ٛ ِٓ ٔٛع ف١ٍجظ أد١ٕ١ب 
 حىِٟٛ .اٌ
 ِصبثخ ثّشض اٌزلاع١ّ١ب  لا رشىٛ ِٓ اٌزلاع١ّ١ب ٚاخشٜ ؼج١ؼ١خثبثش سخؼٟ ٚثشىً ِمبسٔٗ ث١ٓ حبلاد  رّذ اٌذساعخ 
 .2170ٚاراس  2170ِب ث١ٓ وبْٔٛ اٌثبٟٔ  اٌفزشح خلاي ٚرّذ 
 اٌؽج١خ دذاَ صٛس اٌشٔ١ٓ اٌّغٕبؼ١غٟ ٚاٌغدلاح١ث رُ اعزخ, اٌفش٠ز١ٓٚرُ ِمبسٔٗ إٌزبئح ِغ ِغزٛ٠بد ِصً 
 .اٌفشق ث١ٓ اٌحذ٠ذ اٌضائذ فٟ ػعٍذ اٌمٍت ٚاٌىجذ ِٕبلشخ ٌٍّشظٝ ثبثش سخؼٟ وّب رّذ
ٔبٔٛ  201سٞ باٌّؼ١ ٚالأحشاف .جرام لكل ميل ٔبٔٛ خشاَ 7010لاد اٌفش٠ز١ٓ ث١ٓ اٌحبِصً  ِؼذيوبْ  :الىتائج    
ِ١ٍدشاَ ٌىً  26.0حذ٠ذ فٟ اٌىجذ ٟٚ٘ ض اٌ١رُ اٌؼثٛس ػٍٝ اسرجبغ وج١ش فٟ اٌّشض ث١ٓ رشو. خشاَ ٌىً ِ١ً خشاَ
ٚوزٌه رُ اٌؼثٛس ػٍٝ اسرجبغ وج١ش ٌٚىٓ اظؼف فٟ  ,ذثبٌحذ٠ٚرشجغ اٌىجذ  )ِٓ ٔغ١ح اٌؼعٛ خشاَ (اٌٛصْ اٌدبف
ذ ِؼذلاد ح١ث وبٔ  .)ِ١ٍدشاَ 2( ٚوبٔذ اٌمٍت ِٚغزٛ٠بد ِصً اٌفش٠ز١ٓ خاٌّشظٝ ث١ٓ رشو١ض اٌحذ٠ذ فٟ ػعٍ
 ِشظٝ غ١ش ؼج١ؼ١خ فٟ اٌمٍت. 3ٚ ػٕذ  اٌىجذؼ١خ فٟ غ١ش ؼج١ِش٠ط  11 اٌحذ٠ذ ػٕذ
ٟ٘  ,)2T/1( 2R,)*2T/1( *2R اٌزٟ رمبط ثبٌشٔ١ٓ اٌّغٕبؼ١غٟ  اٌؼشظ١خ الاعزشخبء: اْ ِؼذلاد  الخلاصح  
وّب أٙب اظٙشد  ,ٌزمذ٠ش رشعت اٌحذ٠ذ فٟ اٌىجذ ٚاٌمٍت ٌٍّشظٝ اٌز٠ٓ ٠ؼبْٔٛ ِٓ اٌزلاع١ّ١ب اٌىجشٜ ,ٚإِخ ٖ ل١ّٗ ااد
 ,فبع فٟ رشو١ض اٌحذ٠ذ فٟ اٌىجذ ٚاٌمٍت ػٍٝ اٌشغُ ِٓ اْ ِغزٛ٠بد ِصً اٌفش٠ز١ٓ ِٕخفعٗ فٟ ِشظٝ اٌزلاع١ّ١باسر
اٌٝ رشو١ض اٌؼلاج ثبعزخذاَ الاعزحلاة ٚاعزخشاج اٌحذ٠ذ اٌّزشاوُ ٚ٘زا ثحبخٗ اٌٝ رأو١ذ  اٌّبعخ  ِّب ٠ش١ش اٌٝ اٌحبخٗ
 ِٓ دساعبد ِغزمجٍ١ٗ اٚعغ ٚاشًّ.
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QUDS University and Palestinian Ministry of Health, the permission was given to each 
member of the study and participating. All the information was given to patients and the 
participating, Without coercion or coercion and the members were given the freedom to 
agree to join the research or not to participate freely and the patient was given the option 
to accept or refuse to participate in the study. Each participant in this study was informed 
in detail about the method of work of the study and how the work of the examination in 
full and he signed and approved the work of that study. 
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Appendices 
Appendix 1:  Patient check list for MRI 
 
□ date for scheduling clinical diagnose  
□ Recruits of patient inform (Clinicians) 
□ The request form for MRI exam  (support in  personnel patient). 
□ Clinical patient Form (Clinicians) 
□ MRI protocol list form for safety and protect (, targeted exams) and software for  
□ Saving procedures for MRI study 
□ Transfer DICOM images to Packs System (Radiologists) 
□ Transfer Clinical data to HIS  (Clinicians) 
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Appendix 2 Patient Check List  
Patient check list that should be written on the day of exam. 
Patient Name :   .............................Patient ID…………………………. Date of 
Birth:    /      /.       …..length in cm:     …………………...Weight in 
Kg……………………… 
. It is necessary for the benefit of the patient and the interest of the technical staff to be 
filled out this questionnaire, in order to: ensure the safety of the patient, the accuracy of 
the examination, and in order not to risk the risk on you and the technical staff, please be 
correct, accurate and complete where it will be signed, and approved as an official 
document by the technical staff. 
  Do you have (or have you ever had) the following?  
Pacemaker  Yes   No 
Pacing wires / defibrillator / PICC line  Yes   No 
Brain aneurysm clip  Yes   No 
Cochlear Implant Yes     No 
Artificial heart valve  Yes   No 
Neurostimulator / Bio stimulator  Yes   No 
IVC filter  Yes   No 
Any type of intravascular coils, filters or stents  Yes   No 
Swans-Ganz catheter  Yes   No 
Brain shunt tube  Yes   No 
Metal pin, plates, rods, screws, prostheses  Yes   No 
Ocular (eye) prosthesis  Yes   No 
Stapes (ear) implant  Yes   No 
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I sign on that I understood and understood all of the questionnaire contained in the 
questionnaire without coercion or ignorance of the former and I signed 
 
 Patient or parents  signature :    Date of signature:  
……./…./….. 
 
Any other form of implant  Yes   No 
Hearing Aid  Yes   No 
Dentures, braces (including magnetically activated dentures)  Yes    No 
Transdermal (skin) patches e.g. Nicotine patches  Yes   No 
Shrapnel or bullet wounds Yes     No 
Wig, toupee, hairpiece Yes     No 
A tattoo (including tattooed eyeliner) Yes     No 
Any type of body piercing  Yes   No 
Implanted pain relief pump  Yes   No 
Implanted Insulin Pump Yes   No 
Asthma  Yes   No 
Anemia Yes   No 
Kidney disease  Yes   No 
An angiogram performed  Yes   No 
An operation in the last six weeks  Yes   No 
Do you understand all these questions? Yes     No 
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 ومورج استثيان سلامح المرضى واستمارج الموافقح على التصوير تالرويه المغىاطيسي 
٘زا الاعزج١بْ ِٓ اخً ِٛافمزىُ ػٍٝ اٌغّبذ ثؼًّ رصٛ٠ش ثبٌشٔ١ٓ اٌّغٕبؼ١غٟ ٌٍىجذ ٚاٌمٍت ِٓ اخً  ل١بط ِٚؼشفخ 
اٌزصٛ٠ش ثبٌشٔ١ٓ  ػٍّب اْ دلبئك  حوّ١خ اٌحذ٠ذ اٌّخضٔخ فٟ اٌمٍت ٚاٌىجذ ح١ث اْ ِذح اٌزصٛ٠ش لا رزؼذٜ ػشش
ٚ٘زا  اٌّغٕبؼ١غٟ ٘ٛ ؼش٠مخ ٌزصٛ٠ش اٌدغُ ثبعزخذاَ ِٛخبد اٌشاد٠ٛ اٌغ١ش ظبسح. ٚلا رٛخذ أشؼخ ع١ٕ١خ ظبسح.
ثحث ػٍّٟ ٠ششف ػٍ١ٗ اعبرزح ِخزصْٛ ِٓ خبِؼخ اٌمذط وٍ١خ اٌذساعبد اٌؼٍ١ب د. ِحّذ حدٛج ٚدائشح اٌزصٛ٠ش 
٘زا اٌجحث خضءا اعبع١ب ِٓ ِششٚع سعبٌخ ِبخغز١ش اٌزٞ الَٛ ثٗ فٟ لغُ  اٌؽجٟ فٟ خبِؼخ اٌمذط اثٛ د٠ظ .ٚ٠شىً
  ِغبس اٌزصٛ٠ش اٌٛظ١فٟ.–اٌزصٛ٠ش اٌؽجٟ 
ٔبًِ اْ رزىشِٛا ػٍ١ٕب ثبٌّشبسوخ فٟ ٘زٖ اٌذساعخ اٌؼٍّ١خ ٌخذِخ اٌّشظٝ رٚٞ اٌؼلالخ ٚخذِخ اٌمؽبع اٌصحٟ 
 اٌفٍغؽ١ٕٟ
    ⃝  لا اٚافك                                       ⃝ٚرؽٛ٠ش اٌجحث اٌؼٍّٟ .     اٚافك   
اسخٛ اْ رغّحٛا ٌٟ ثؼًّ ٘زا اٌزصٛ٠ش  ٌّشح ٚاحذح ػٍّب اْ خّ١غ اٌج١بٔبد ٚاٌّؼٍِٛبد عش٠خ ٚرخص ٘زا اٌجحث 
 اٌؼٍّٟ فمػ .ٌٚىُ اٌحك فٟ الأغحبة ِٓ اٌّشبسوخ ِزٝ شئزُ .
  . ثٛػشلٛةأثغبَ ػجذاٌؼض٠ض ِٛعٝ   ِغ الاحزشاَ :
          ..................................................................سلُ اٌٙٛ٠خ..............................................الاعُ:...
  .....ربس٠خ اٌّ١لاد:.................................................................. اٌٛصْ (وٍغ).................................
  ....ؼج١ؼخ ػٍّه..................................................................اٌجش٠ذ الاٌىزشٟٚٔ................................
  .......اٌدٕظ..........................................................اٌٙبرف...................................................
 ً٘ ٌذ٠ه أٞ خغُ غش٠ت ِؼذٟٔ اٚ سلؼخ ؼج١خ ِؼذٔ١خ، إرا وبٔذ الإخبثخ ثٕؼُ ، ِزٝ وبْ ربس٠خ ٘زٖ اٌضسػخ اٌّؼذٔ١خ اٌؽج١خ؟
 .. ........................................................
  ..............................ً٘ ٌذ٠ه ٚثبئك حٛي اٌضسع ٚسلّٗ اٌّزغٍغً؟....................................
  ً٘ رؼبٟٔ ِٓ ٔٛثبد ِٕزظّخ؟...................................................................................
 ً٘ ٌذ٠ه اخزجبس حذ٠ث ٌٛظبئف اٌىٍٝ.........................................................................  
 ً٘ ٌذ٠ه اظؽشاة وٍٛ٠خ  ..................................................................................
 ً٘ ػٕذن خٛف  ِٓ الأِبوٓ اٌّغٍمخ؟ .............................................................
  ٌذ٠ه سد فؼً رحغغٟ لأٞ ٔٛع ِٓ الأدٚ٠خ؟ ً٘ .............................................................
 ً٘ ٌذ٠ه أٞ ػٍّ١خ خشاح١خ ، إرا وبٔذ الإخبثخ ثٕؼُ ، ِزٝ وبْ ربس٠خ اٌؼٍّ١خ......................................... 
 ً٘ أٔزٟ ، أٚ ً٘ ٠ّىٓ أْ رىٟٛٔ حبًِ؟ .................................................................
  ٔزٟ  ِشظؼخ؟.....................................................................................................أ ً٘
ٌمذ لشأد ٚفّٙذ ٚأوٍّذ ػٍٝ حذ ػٍّٟ ، الأعئٍخ اٌٛاسدح فٟ إٌّٛرج  ٚلّذ ثبٌّٛافمخ ػٍٝ ٘زا ٚأٚافك ػٍٝ اٌزصٛ٠ش ثبٌشٔ١ٓ 
  ٍٛة.اٌّغٕبؼ١غٟ ٌؼًّ اٌفحص اٌّؽ
  .......رٛل١غ اٌّش٠ط.........................................ربس٠خ اٌزٛل١غ...........................................................
  ..............ربس٠خ اٌزٛل١غ.........................................اٌزصٛ٠ش ثبٌشٔ١ٓ اٌّغٕبؼ١غٟ.................. اخزصبصٟ رٛل١غ رمٕٟ
 
